| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C315-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C319-20 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C315-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-48 |
| filingDate |
1998-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c7f5b34e50a2aaf7d0204406e0e3cec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d741d003091220ee7492b08f2d9d4e7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2a26dd01f5d4cd2248e7a66efacfd64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04ab25671d5759aa8918447f12eb4d87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17db1dc4fb6586f71c887af38eda3470 |
| publicationDate |
2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6153787-A |
| titleOfInvention |
Intermediates for making heterocycles useful as COX-2 inhibitors |
| abstract |
The invention encompasses a process for making compounds of Formula I or Ia useful in the treatment of cyclooxygenase-2 mediated diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005014729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005113409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7449462-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008077599-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2196201-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004220155-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004072889-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005119262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007225333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003220374-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004147581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003212138-A1 |
| priorityDate |
1996-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |